Correlation Between Caribou Biosciences and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Unicycive Therapeutics, you can compare the effects of market volatilities on Caribou Biosciences and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Unicycive Therapeutics.
Diversification Opportunities for Caribou Biosciences and Unicycive Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Caribou and Unicycive is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Unicycive Therapeutics
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Unicycive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.2 times less risky than Unicycive Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Unicycive Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 55.00 in Unicycive Therapeutics on September 24, 2024 and sell it today you would earn a total of 13.00 from holding Unicycive Therapeutics or generate 23.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Unicycive Therapeutics
Performance |
Timeline |
Caribou Biosciences |
Unicycive Therapeutics |
Caribou Biosciences and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Unicycive Therapeutics
The main advantage of trading using opposite Caribou Biosciences and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Unicycive Therapeutics vs. Fate Therapeutics | Unicycive Therapeutics vs. Sana Biotechnology | Unicycive Therapeutics vs. Caribou Biosciences | Unicycive Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |